Literature DB >> 27571754

Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis.

Direk Limmathurotsakul1,2,3, Nick Golding1, David A B Dance4,5, Jane P Messina6, David M Pigott1, Catherine L Moyes1, Dionne B Rolim7, Eric Bertherat8, Nicholas P J Day2,5, Sharon J Peacock2,9,10, Simon I Hay1,11,12.   

Abstract

Burkholderia pseudomallei, a highly pathogenic bacterium that causes melioidosis, is commonly found in soil in Southeast Asia and Northern Australia(1,2). Melioidosis can be difficult to diagnose due to its diverse clinical manifestations and the inadequacy of conventional bacterial identification methods(3). The bacterium is intrinsically resistant to a wide range of antimicrobials, and treatment with ineffective antimicrobials may result in case fatality rates (CFRs) exceeding 70%(4,5). The importation of infected animals has, in the past, spread melioidosis to non-endemic areas(6,7). The global distribution of B. pseudomallei and the burden of melioidosis, however, remain poorly understood. Here, we map documented human and animal cases and the presence of environmental B. pseudomallei and combine this in a formal modelling framework(8-10) to estimate the global burden of melioidosis. We estimate there to be 165,000 (95% credible interval 68,000-412,000) human melioidosis cases per year worldwide, from which 89,000 (36,000-227,000) people die. Our estimates suggest that melioidosis is severely underreported in the 45 countries in which it is known to be endemic and that melioidosis is probably endemic in a further 34 countries that have never reported the disease. The large numbers of estimated cases and fatalities emphasize that the disease warrants renewed attention from public health officials and policy makers.

Entities:  

Mesh:

Year:  2016        PMID: 27571754     DOI: 10.1038/nmicrobiol.2015.8

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  258 in total

1.  Epidemiology: A global picture of melioidosis.

Authors:  Bart J Currie; Mirjam Kaestli
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

Review 2.  Novel multi-component vaccine approaches for Burkholderia pseudomallei.

Authors:  L Morici; A G Torres; R W Titball
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

3.  Rapid Filter-Based Detection and Culture of Burkholderia pseudomallei from Small Volumes of Urine.

Authors:  Pierre A Michel; Christine Lascols; Jay E Gee; Linda M Weigel; David Sue
Journal:  J Clin Microbiol       Date:  2017-06-21       Impact factor: 5.948

4.  Malleilactone Is a Burkholderia pseudomallei Virulence Factor Regulated by Antibiotics and Quorum Sensing.

Authors:  Jennifer R Klaus; Jacqueline Deay; Benjamin Neuenswander; Wyatt Hursh; Zhe Gao; Tiffany Bouddhara; Todd D Williams; Justin Douglas; Kyle Monize; Patricia Martins; Charlotte Majerczyk; Mohammad R Seyedsayamdost; Blake R Peterson; Mario Rivera; Josephine R Chandler
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

5.  Differences in Inflammation Patterns Induced by African and Asian Burkholderia pseudomallei Isolates in Mice.

Authors:  Tassili A F Weehuizen; Emma Birnie; Bart Ferwerda; Joris J T H Roelofs; Alex F de Vos; Martin P Grobusch; W Joost Wiersinga
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

6.  Bacteriophage-associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848.

Authors:  David DeShazer; Sean Lovett; Joshua Richardson; Galina Koroleva; Kathleen Kuehl; Kei Amemiya; Mei Sun; Patricia Worsham; Susan Welkos
Journal:  J Med Microbiol       Date:  2019-01-10       Impact factor: 2.472

7.  Role of Toll-Like Receptor 5 (TLR5) in Experimental Melioidosis.

Authors:  Emma Birnie; Tassili A F Weehuizen; Jacqueline M Lankelma; Hanna K de Jong; Gavin C K W Koh; Miriam H P van Lieshout; Joris J T H Roelofs; Andries E Budding; Alex F de Vos; Tom van der Poll; W Joost Wiersinga
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 8.  Regulation of Virulence by Two-Component Systems in Pathogenic Burkholderia.

Authors:  Matthew M Schaefers
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 9.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

10.  Use of Rapid Enzyme-Linked Immunosorbent Assays for Serological Screening of Melioidosis in Myanmar.

Authors:  Zin Zayar Win; Phornpun Phokrai; Zarni Aung; Thein Zaw; Mary N Burtnick; Narisara Chantratita; Paul J Brett; Tin Maung Hlaing
Journal:  Am J Trop Med Hyg       Date:  2018-03-15       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.